Amring Pharmaceuticals Inc. Enters into License and Development Agreement with Amzell B.V.
BioTech 365
MARCH 12, 2021
Amring Pharmaceuticals Inc. –(BUSINESS WIRE)–Amring Pharmaceuticals Inc. Amring), a niche brand and generic pharmaceutical company, announced today an … Continue reading → Enters into License and Development Agreement with Amzell B.V. BERWYN, Pa.–(BUSINESS
Let's personalize your content